Financhill
Sell
42

CTSH Quote, Financials, Valuation and Earnings

Last price:
$76.41
Seasonality move :
0.39%
Day range:
$75.50 - $76.95
52-week range:
$63.79 - $90.82
Dividend yield:
1.58%
P/E ratio:
16.94x
P/S ratio:
1.93x
P/B ratio:
2.62x
Volume:
9.5M
Avg. volume:
4.6M
1-year change:
5.29%
Market cap:
$37.8B
Revenue:
$19.7B
EPS (TTM):
$4.51

CTSH Analysts' Consensus Rating

The 26 analysts providing 12-month price projections for Cognizant Technology Solutions shares anticipate an average target of $88.68, ranging from a low estimate of $80.00 to a high estimate of $103.00. This average target implies a growth of 16.05% compared to the current stock price of $76.42.

Consensus Price Target

$88.68

Highest Price Target

$103.00

Lowest Price Target

$80.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 5 2 3

Hold 20 23 22

Sell 1 1 1
Consensus Hold Hold Hold

CTSH Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock